Patent details
EP1696932 Title: USE OF TREPROSTINIL TO IMPROVE KIDNEY FUNCTIONS
Basic Information
- Publication number:
- EP1696932
- PCT Application Number:
- PCT/US/2004/042119
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP048143184
- PCT Publication Number:
- WO/2005/058329
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- USE OF TREPROSTINIL TO IMPROVE KIDNEY FUNCTIONS
- French Title of Invention:
- AMELIORATION DES FONCTIONS RENALES PAR LE TREPROSTINIL
- German Title of Invention:
- VERWENDUNG VON TREPROSTINIL ZUR VERBESSERUNG DER NIERENFUNKTION
- SPC Number:
Dates
- Filing date:
- 16/12/2004
- Grant date:
- 02/09/2009
- EP Publication Date:
- 02/09/2009
- PCT Publication Date:
- 30/06/2005
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 06/09/2006
- EP B1 Publication Date:
- 02/09/2009
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 16/12/2009
- Expiration date:
- 16/12/2024
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 16/12/2004
- Name:
- United Therapeutics Corporation
- Address:
- 1735 Connecticut Avenue, N.W. Third Floor, Washington, DC 20009, United States (US)
Inventor
1
- Name:
- WADE Michael, United Therapeutics Corp.
- Address:
- United States (US)
2
- Name:
- STROOTMAN Deborah, United Therapeutics
- Address:
- United States (US)
3
- Name:
- BRONSTEIN Kathryn
- Address:
- United States (US)
4
- Name:
- JEFFS Roger, Andrew, United Therapeutics Corp.
- Address:
- United States (US)
Priority
- Priority Number:
- 529621 P
- Priority Date:
- 16/12/2003
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 31/5575;
| Filing date | Document type | Number of pages |
|---|